Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Study: Air pollution, impaired lung function independently affect cognition

Studies have shown that both air pollution and impaired lung function can cause cognitive deficits, but it was unclear whether air pollution diminishes cognition by reducing breathing ability first or whether air pollution represents an independent risk factor for cognitive deficit.

19 May 2015

Grass plants can bind, uptake and transport infectious prions

Grass plants can bind, uptake and transport infectious prions, according to researchers at The University of Texas Health Science Center at Houston (UTHealth).

18 May 2015

New findings could help better understand neurodegenerative diseases

Researchers at the Luxembourg Centre for Systems Biomedicine (LCSB), of the University of Luxembourg, have, under Dr. Manuel Buttini, successfully measured metabolic profiles, or the metabolomes, of different brain regions, and their findings could help better understand neurodegenerative diseases.

18 May 2015

Research leads way for noninvasive detection of early stage liver cancer

Led by Georgia State University, researchers have developed the first robust and noninvasive detection of early stage liver cancer and liver metastases, in addition to other liver diseases, such as cirrhosis and liver fibrosis.

15 May 2015

Researchers explore how low-level electrical stimulation reduces inflammation

The Feinstein Institute for Medical Research, the research arm of the North Shore-LIJ Health System, and SetPoint Medical Inc., a biomedical technology company, today released the results of research on the therapeutic potential of vagus nerve stimulation. In a paper published by Bioelectronic Medicine, Kevin J. Tracey, MD, and his colleagues at the Feinstein Institute, explore how low-level electrical stimulation interacts with the body's nerves to reduce inflammation, a fundamental goal of bioelectronic medicine.

15 May 2015

Denali launched to discover, develop effective medicines for neurodegenerative diseases

Denali Therapeutics Inc., a new biotechnology company focused on developing effective therapies for neurodegenerative diseases, announced today that it has launched with an initial investment commitment of $217 million.

14 May 2015

Growth of neuronal and vascular networks is controlled by same signaling molecules

Neurons and blood vessels often traverse the body side by side, a fact observed as early as the 16th century by the Flemish anatomist Andreas Vesalius. Only over the last ten years, however, researchers have discovered that the growth of neuronal and vascular networks is controlled by the same molecules.

14 May 2015

New work challenges long-held beliefs about link between hippocampus and improved memory function

New work by the Douglas Mental Health University Institute (CIUSSS de l'Ouest-de-l'île-de-MontréalI) computational neuroscientist Mallar Chakravarty, PhD, and in collaboration with researchers at the Centre for Addiction and Mental Health challenges in a thrilling way the long-held belief that a larger hippocampus is directly linked to improved memory function.

14 May 2015

Eating Mediterranean diet helps delay cognitive decline

Professor of Preventive Medicine at the University of Valencia Dolors Corella is part of the multidisciplinary team conducting the Predimed study, which has found that eating a Mediterranean diet, enriched with olive oil or nuts, helps delay cognitive decline.

13 May 2015

Repetitive head injuries may accelerate aging process, increase dementia risk

Repetitive head injuries that occur during contact sports and military service may accelerate the aging process by increasing the build-up of beta-amyloid in the brain, leading to worse disease and an increased likelihood of developing dementia. In particular, boxers fared the worst among athletes and military veterans with a history of head injuries.

13 May 2015

Discovery paves way for developing treatments for people addicted to cocaine, amphetamines

In a major advance in the field of neuropsychiatry, researchers in the Vollum Institute at Oregon Health & Science University have illuminated how cocaine and amphetamines disrupt the normal functioning of the dopamine transporter in the brain.

12 May 2015

Study finds link between PTSD and accelerated aging

In recent years, public health concerns about post-traumatic stress disorder (PTSD) have risen significantly, driven in part by affected military veterans returning from conflicts in the Middle East and elsewhere. PTSD is associated with number of psychological maladies, among them chronic depression, anger, insomnia, eating disorders and substance abuse.

10 May 2015

β-amyloid deposition highly variable in synucleinopathy

A meta-analysis suggests large variability in the prevalence of β-amyloid deposition in patients with synucleinopathies.

8 May 2015

Creating digital technology prototypes to improve dementia care

A health-inspired hackathon is taking place in Newcastle-Upon-Tyne, UK, with the aim of creating digital technology prototypes to support dementia care. Designers, coders, hackers and researchers are invited to take part in Create-4-Dementia on May 30th and 31st - the first public event of the Social Computing and Mental Health Research Network led by the University of Lincoln, UK, and funded by the Engineering and Physical Sciences Research Council.

8 May 2015

Knowing the physical structure of amyloid beta-42 offers new view on amyloid propagation in Alzheimer's

Researchers at the University of Illinois at Chicago have determined the molecular structure of one of the proteins in the fine fibers of the brain plaques that are a hallmark of Alzheimer's disease. This molecule, called amyloid beta-42, is toxic to nerve cells and is believed to provoke the disease cascade.

8 May 2015

GTEx findings reveal how genomic variants can affect gene activity and disease susceptibility

Researchers funded by the National Institutes of Health Genotype-Tissue Expression (GTEx) project have created a new and much-anticipated data resource to help establish how differences in an individual's genomic make-up can affect gene activity and contribute to disease.

8 May 2015

Roll-out of eMR-ABC software in Indiana may benefit older adults with dementia or depression

Older Indiana adults with dementia or depression will be among the best cared for elders in the nation beginning this month with the statewide roll-out of a unique automated decision-support system that enables their care coordinators to meet the complex bio-psychosocial needs of these individuals as well as those of their family members and other informal caregivers.

8 May 2015

NIH-sponsored Phase 1 clinical trial evaluates novel investigational West Nile virus vaccine

A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored Phase 1, first-in-human, clinical trial at Duke University. Although several early-stage West Nile virus vaccine clinical trials have been completed to date, no human vaccine has been approved for commercial use.

7 May 2015

New epilepsy drug holds promise as Alzheimer's treatment

University of British Columbia researchers say a new epilepsy drug holds promise as a treatment for Alzheimer's disease.

7 May 2015

Wearable cognitive assessment devices a step closer as Cambridge Cognition file new patents

The combination of bio-behavioural measures and results from touch-screen cognitive tests would be used to build up a picture of a person’s mental function...

7 May 2015

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Study: Air pollution, impaired lung function independently affect cognition

Grass plants can bind, uptake and transport infectious prions

New findings could help better understand neurodegenerative diseases

Research leads way for noninvasive detection of early stage liver cancer

Researchers explore how low-level electrical stimulation reduces inflammation

Denali launched to discover, develop effective medicines for neurodegenerative diseases

Growth of neuronal and vascular networks is controlled by same signaling molecules

New work challenges long-held beliefs about link between hippocampus and improved memory function

Eating Mediterranean diet helps delay cognitive decline

Repetitive head injuries may accelerate aging process, increase dementia risk

Discovery paves way for developing treatments for people addicted to cocaine, amphetamines

Study finds link between PTSD and accelerated aging

β-amyloid deposition highly variable in synucleinopathy

Creating digital technology prototypes to improve dementia care

Knowing the physical structure of amyloid beta-42 offers new view on amyloid propagation in Alzheimer's

GTEx findings reveal how genomic variants can affect gene activity and disease susceptibility

Roll-out of eMR-ABC software in Indiana may benefit older adults with dementia or depression

NIH-sponsored Phase 1 clinical trial evaluates novel investigational West Nile virus vaccine

New epilepsy drug holds promise as Alzheimer's treatment

Wearable cognitive assessment devices a step closer as Cambridge Cognition file new patents

Innovation in neuroscience drug discovery - eBook eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Innovation in neuroscience drug discovery - eBook eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in